Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mozenavir. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2004-12-01

A combined QM/MM approach to protein--ligand interactions: polarization effects of the HIV-1 protease on selected high affinity inhibitors.

Hensen C, Hermann JC, Nam K, Ma S, Gao J, Höltje HD.

J Med Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1021/jm0497343

Bibliografisk träff 1999-01-01

Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors.

De Lucca GV, Liang J, De Lucca I.

J Med Chem · journal article · DOI 10.1021/jm9803626

Bibliografisk träff 1999-01-01

Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.

Debnath AK.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm980369n

Bibliografisk träff 1998-06-01

Cyclic HIV protease inhibitors: design and synthesis of orally bioavailable, pyrazole P2/P2' cyclic ureas with improved potency.

Han Q, Chang CH, Li R, Ru Y, Jadhav PK, Lam PY.

J Med Chem · journal article · DOI 10.1021/jm9704199

Bibliografisk träff 1998-06-01

Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.

De Lucca GV, Kim UT, Liang J, Cordova B, Klabe RM, Garber S, Bacheler LT, Lam GN, Wright MR, Logue KA, Erickson-Viitanen S, Ko SS, Trainor GL.

J Med Chem · journal article · DOI 10.1021/jm980103g

Bibliografisk träff 1998-04-01

Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.

Jadhav PK, Woerner FJ, Lam PY, Hodge CN, Eyermann CJ, Man HW, Daneker WF, Bacheler LT, Rayner MM, Meek JL, Erickson-Viitanen S, Jackson DA, Calabrese JC, Schadt M, Chang CH.

J Med Chem · comparative study; journal article · DOI 10.1021/jm970524i

Bibliografisk träff 1998-04-01

The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues.

Patel M, Bacheler LT, Rayner MM, Cordova BC, Klabe RM, Erickson-Viitanen S, Seitz SP.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(98)00119-x

Bibliografisk träff 1997-12-01

Nonsymmetrically substituted cyclic urea HIV protease inhibitors.

Wilkerson WW, Dax S, Cheatham WW.

J Med Chem · journal article · DOI 10.1021/jm970288b

Bibliografisk träff 1997-01-01

Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.

Jadhav PK, Ala P, Woerner FJ, Chang CH, Garber SS, Anton ED, Bacheler LT.

J Med Chem · journal article · DOI 10.1021/jm960586t